Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyberonics, Inc.'s financial performance into perspective.

Recent Releases

May 16, 2012
Cyberonics To Report Fourth Quarter And Fiscal Year 2012 Results And Host Conference Call On June 6, 2012

Mar 6, 2012
Cyberonics to Present at Sidoti 16th Annual Emerging Growth Research Institutional Investor Forum

View all releases »

Events & Presentations

Jun 6, 2012 at 9:00 AM ET
Cyberonics Earnings Conference Call - Q4 FY2012 Results

View all events & presentations »